Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics AG shares valued at $1,173,232 were sold by Kulkarni Samarth on Apr 15 ’24. At $59.91 per share, Kulkarni Samarth sold 19,582 shares. The insider’s holdings dropped to 208,122 shares worth approximately $11.69 million following the completion of this transaction.
Also, Kulkarni Samarth sold 20,000 shares, netting a total of over 1,449,628 in proceeds. Following the sale of shares at $72.48 each, the insider now holds 208,122 shares.
Before that, Prasad Raju had sold 3,524 shares from its account. In a trade valued at $256,160, the Chief Financial Officer traded CRISPR Therapeutics AG shares for $72.69 each. Upon closing the transaction, the insider’s holdings decreased to 3,524 shares, worth approximately $0.36 million.
As published in their initiating research note from Wolfe Research on February 15, 2024, CRISPR Therapeutics AG [CRSP] has been a Peer perform. Analysts at TD Cowen downgraded the stock from ‘”a Market perform”‘ to ‘”an Underperform”‘ outlook in a report released in mid December. As of October 17, 2023, Cantor Fitzgerald has decreased its “an Overweight” rating to a “Neutral” for CRSP. Earlier on September 27, 2023, Mizuho initiated its rating. Their recommendation was “a Buy” for CRSP stock.
Analyzing CRSP Stock Performance
During the last five days, there has been a drop of approximately -10.73%. Over the course of the year, CRISPR Therapeutics AG shares have dropped approximately -10.29%. Shares of the company reached a 52-week high of $91.10 on 02/22/24 and a 52-week low of $55.25 on 04/18/24. A 50-day SMA is recorded $72.94, while a 200-day SMA reached $59.58. Nevertheless, trading volume fell to 1.74 million shares from 1.18 million shares the previous day.
Support And Resistance Levels for CRISPR Therapeutics AG (CRSP)
According to the 24-hour chart, there is a support level at 54.93, which, if violated, would cause prices to drop to 53.70. In the upper region, resistance lies at 57.71. The next price resistance is at 59.26. RSI (Relative Strength Index) is 26.37 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -5.49, which suggests the price will decrease in the coming days. Percent R is at 93.07%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
